Newron Pharmaceuticals S.p.A.
NP5
Peringkat dalam Saham
#17872
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Harga Saham
$10.32
Kapitalisasi Pasar
$211.01M
Perubahan (1 hari)
-2.25%
Perubahan (1 tahun)
-40.13%
Negara
IT
Perdagangan Newron Pharmaceuticals S.p.A. (NP5)
Kategori
Healthcare
Kapitalisasi pasar dari Newron Pharmaceuticals S.p.A.(NP5)
Kapitalisasi Pasar: $211.01M
Per October 2026, Newron Pharmaceuticals S.p.A. memiliki kapitalisasi pasar sebesar $211.01M. Ini menjadikan Newron Pharmaceuticals S.p.A. sebagai perusahaan 17872nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Newron Pharmaceuticals S.p.A. dari 2015 hingga 2026
NP5 dibandingkan dengan 5 teratas stocks paling populer
